THBS4, thrombospondin 4, 7060

N. diseases: 59; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0040420
Disease: Tonometry
Tonometry
0.100 GeneticVariation phenotype GWASCAT Genome-wide association analyses identify new loci influencing intraocular pressure. 29617998 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease BEFREE None of studied single genetic variants-F13A1 Val34Leu, THBS2 T/G 3'UTR and THBS4 Ala387Pro-and the extended CC/TT/GG haplotype of F13A1/THBS2/THBS4 genes was associated with MI in young age. 30972713 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.060 AlteredExpression group BEFREE The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer. 31703077 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 AlteredExpression disease BEFREE Thrombospondin 4 (TSP-4) expression is induced in the heart and vasculature under pathological conditions, including myocardial infarction, myocardial pressure overload, and hypertension. 29729633 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.060 Biomarker group BEFREE Upregulation of pro-angiogenic TSP-4 and selective effects of TSP-4 on EC may contribute to stimulation of tumor growth by TGF-β despite the inhibition of cancer cell proliferation. 28481870 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.060 AlteredExpression group BEFREE While THBS4 is often overexpressed in HCC it has also been shown to inhibit tumor growth by mediating cell-to-cell and cell-to-matrix interactions. 28177895 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.060 AlteredExpression group BEFREE THBS4 mRNA expression in human stomach was associated with tumor size (P = 0.002) and tumor-node-metastasis (TNM) (P = 0.010), and THBS2 mRNA expression was associated with the TNM (P = 0.010). 27160021 2016
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.060 Biomarker group BEFREE THBS4 may act as a tumour suppressor gene, demonstrated by its suppression of tumour colony formation in vitro. 20846368 2010
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease LHGDN Based on a study examining 500 myocardial infarction (MI) patients and 500 controls from the genetically isolated Newfoundland population, we previously reported that thrombospondin-4 (THBS-4) 1186G>C variant associates with MI in women. 16923428 2006
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease BEFREE Based on a study examining 500 myocardial infarction (MI) patients and 500 controls from the genetically isolated Newfoundland population, we previously reported that thrombospondin-4 (THBS-4) 1186G>C variant associates with MI in women. 16923428 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.060 GeneticVariation group BEFREE Hypermethylation of the putative tumor suppressor genes BCL7a (in 48% of CTCL samples), PTPRG (27%), and thrombospondin 4 (52%) was confirmed and demonstrated to be associated with transcriptional downregulation. 15897551 2005
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease BEFREE Our findings suggest that the A387P variant of the THBS4 gene may be an important determinant in the development of MI at any age. 15131549 2004
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease BEFREE Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population. 14674882 2004
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease BEFREE Homozygosity for the THBS-2 variant allele and the THBS-4 variant (387P) allele was significantly associated with a reduced risk of premature MI compared with wild-type individuals (OR=0.44, 0.24 to 0.84 and OR=0.43, 0.22 to 0.85, respectively). 12482844 2002
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.050 Biomarker phenotype BEFREE These results provide biochemical evidence that supports a specific role of TSP-4 among the TSPs in mediating the binding to neuronal α<sub>2</sub>δ-1 and suggest that gabapentin does not directly target TSP/α<sub>2</sub>δ-1 interaction to alleviate neuropathic pain. 31700036 2019
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.050 Biomarker phenotype BEFREE Up-regulation of thrombospondin-4 (TSP4) or voltage-gated calcium channel subunit α<sub>2</sub>δ<sub>1</sub> (Ca<sub>v</sub>α<sub>2</sub>δ<sub>1</sub>) proteins in the spinal cord contributes to neuropathic pain development through an unidentified mechanism. 30194282 2018
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.050 Biomarker phenotype BEFREE Nerve injury induces concurrent up-regulation of the voltage-gated calcium channel subunit Ca<sub>v</sub> α<sub>2</sub> δ<sub>1</sub> and the extracellular matrix protein thrombospondin-4 (TSP4) in dorsal root ganglia and dorsal spinal cord, leading to the development of a neuropathic pain state. 29338087 2018
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.050 Biomarker phenotype BEFREE Controlling TSP4 mediated intracellular Ca<sup>2+</sup> signaling in peripheral sensory neurons may be a target for analgesic drug development for neuropathic pain. 28232180 2017
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.050 Biomarker phenotype BEFREE Development of TSP4 antagonists has the therapeutic potential for target-specific neuropathic pain management. 22745497 2012
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 AlteredExpression group BEFREE THBS4 expression in cancer-associated fibroblasts (CAFs), normal-associated fibroblasts (NFs) and gastric cancer cell lines was examined by western blotting. 31703077 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 AlteredExpression group BEFREE The aim of this study was to study THBS4 expression in hepatocellular carcinoma (HCC) and determine if it was a prognostic marker for this malignancy. 30802535 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 Biomarker group BEFREE Further, the bioinformatics analysis of the cancer genome atlas dataset suggested that there may be a positive correlation between THBS4 and KLF9 expression. 30746617 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 AlteredExpression disease BEFREE The analysis of Gene Expression Omnibus (GEO) dataset (GSE26253) suggested that THBS4 was up-regulated in recurrent GC patients and was positively correlated with the increase in pathological stage and poor prognosis in GC. 30746617 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 AlteredExpression disease BEFREE THBS4 is expressed on CAFs in the gastric cancer microenvironment. 31703077 2019
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE The analysis of Gene Expression Omnibus (GEO) dataset (GSE26253) suggested that THBS4 was up-regulated in recurrent GC patients and was positively correlated with the increase in pathological stage and poor prognosis in GC. 30746617 2019